N,3-diphenylaniline | CAS:198275-79-5

We serve N,3-diphenylaniline CAS:198275-79-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
N,3-diphenylaniline

Chemical Name:N,3-diphenylaniline
CAS.NO:198275-79-5
Synonyms:N-Phenyl-3-biphenylamine
3-Anilinobiphenyl
Molecular Formula:C18H15N
Molecular Weight:245.31800
 
Physical and Chemical Properties:
Density:1.111
Melting point:92ºC
Boiling point:417.7ºC
Flash point:222.6ºC
Index of Refraction:1.646
 
Specification:
Appearance:White powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates



Contact us for information like N,3-diphenylaniline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Anilinobiphenyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Anilinobiphenyl Use and application,3-Anilinobiphenyl technical grade,usp/ep/jp grade.


Related News: Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System.5,6-diethyl-2,3-dihydro-1H-inden-2-amine,hydrochloride manufacturer Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System.2,2'-[5-(Hydroxymethyl)-1,3-phenylene]bis(2-methylpropanenitrile) supplier The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs.1-fluoro-7-chloroheptane vendor Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis.But it has been barred from that body as Beijing has increased pressure on Taiwan under President Tsai Ing-wen, who is skeptical about closer ties with China.